InMode (INMD)
(Delayed Data from NSDQ)
$16.50 USD
+0.34 (2.10%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $16.47 -0.03 (-0.18%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.50 USD
+0.34 (2.10%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $16.47 -0.03 (-0.18%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth D Momentum B VGM
Zacks News
Is InMode (INMD) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (INMD) Outperforming Other Medical Stocks This Year?
Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences
by Zacks Equity Research
Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences
5 Stocks Set to Pop on New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Catalyst Biosciences (CBIO), UFP Industries (UFPI), VeriSign (VRSN), InMode (INMD) and Castle Biosciences (CSTL).
Stock Investors: What's the Next Hot Industry?
by Tracey Ryniec
Technology won't always be on top. There's a bunch of budding industries that could prove to be winners over the next 5 years.
Find Strong Stocks with this New Analyst Coverage Screener
by Benjamin Rains
We screened for strong stocks that recently received new analyst coverage, as we enter the heart of Q3 earnings season...
Zacks.com featured highlights include: Perion Network, Live Oak Bancshares, LexinFintech and InMode
by Zacks Equity Research
Zacks.com featured highlights include: Perion Network, Live Oak Bancshares, LexinFintech and InMode
4 Stocks in Focus on New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Perion (PERI), Live Oak (LOB), LexinFintech (LX) and InMode (INMD).
Moving Average Crossover Alert: InMode
by Zacks Equity Research
InMode is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Surging Earnings Estimates Signal Upside for InMode (INMD) Stock
by Zacks Equity Research
InMode (INMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
InMode (INMD) Surges: Stock Moves 10.6% Higher
by Zacks Equity Research
InMode (INMD) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
InMode (INMD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
InMode (INMD) closed the most recent trading day at $28.07, moving +0.36% from the previous trading session.
InMode (INMD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
InMode (INMD) closed at $31.15 in the latest trading session, marking a +1.1% move from the prior day.
InMode (INMD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, InMode (INMD) closed at $31.15, marking a -1.61% move from the previous day.
InMode (INMD) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
InMode's (INMD) Q1 performance is likely to have been driven by developments in business segments amid coronavirus-led supply disruptions.
InMode (INMD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
InMode (INMD) closed at $24.94 in the latest trading session, marking a +1.96% move from the prior day.
Zacks.com featured highlights include: DHT, Blucora, InMode and Enphase Energy
by Zacks Equity Research
Zacks.com featured highlights include: DHT, Blucora, InMode and Enphase Energy
4 Stocks With High Net Income Ratio to Scoop Up
by Nitish Marwah
Profitability analysis is one of the best ways to evaluate the prospects of a company.
InMode (INMD) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, InMode (INMD) closed at $21.98, marking a -0.86% move from the previous day.
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group
5 Stocks to Buy for 5 Good Reasons
by Sejuti Banerjea
Here are 5 ways to make the most of a difficult market.
6 Defensive Stocks Worth Buying as Coronavirus Cases Rise
by Zacks Equity Research
The current economic slowdown led by rise in coronavirus cases calls for investing in defensive stocks.
Vapotherm (VAPO) in Focus: Stock Moves 6.2% Higher
by Zacks Equity Research
Vapotherm (VAPO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Medtronic (MDT) in Focus: Stock Moves 8% Higher
by Zacks Equity Research
Medtronic (MDT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Zacks Value Trader Highlights: Applied Materials, Garmin, InMode, Microsoft and Synaptics
by Zacks Equity Research
Zacks Value Trader Highlights: Applied Materials, Garmin, InMode, Microsoft and Synaptics
Coronavirus Worries? Screen for Stocks with Management Excellence
by Tracey Ryniec
With the coronavirus sell-off increasing worries about debt, here are 5 companies with low debt to equity ratios.